Global Dry Eye Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 22-Sep-2022
No. of pages: 118
Inquire Before Buying

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Dry Eye Drugs market is projected to reach US$ 19140 million by 2028 from an estimated US$ 9696 million in 2022, at a CAGR of 12.0% during 2023 and 2028.

Global Dry Eye Drugs key players include Novartis AG, Valeant Pharmaceuticals, Allergan, Johnson & Johnson, Santen Pharma, etc. Global top five manufacturers hold a share about 75%.

North America is the largest market, with a share about 40%, followed by Asia-Pacific, and Europe, both have a share about 40 percent.

In terms of product, Artificial Tears is the largest segment, with a share over 85%. And in terms of application, the largest application is Hospital, followed by Drug Stores, Online Pharmacies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dry Eye Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Dry Eye Drugs.

The Dry Eye Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Dry Eye Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dry Eye Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Allergan

- Novartis AG

- Bausch Health

- Santen Pharma

- Takeda

- Johnson & Johnson

- United Laboratories

- Senju Pharmaceutical

- Jianfeng Group

- Eusan GMBH

Product Type Insights

Global markets are presented by Dry Eye Drugs type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Dry Eye Drugs are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Dry Eye Drugs Segment by Type

- Artificial Tears

- Anti-inflammatory Drugs

- Other

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Dry Eye Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Dry Eye Drugs market.

Dry Eye Drugs Segment by Application

- Hospital

- Drug Stores

- Online Pharmacies

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Dry Eye Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Dry Eye Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Dry Eye Drugs industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye Drugs

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Dry Eye Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Dry Eye Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Dry Eye Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Dry Eye Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Dry Eye Drugs Market Size Estimates and Forecasts
2.1.1 Global Dry Eye Drugs Revenue 2017-2028
2.1.2 Global Dry Eye Drugs Sales 2017-2028
2.2 Dry Eye Drugs Market Size by Region: 2022 Versus 2028
2.3 Dry Eye Drugs Sales by Region (2017-2028)
2.3.1 Global Dry Eye Drugs Sales by Region: 2017-2022
2.3.2 Global Dry Eye Drugs Sales Forecast by Region (2023-2028)
2.3.3 Global Dry Eye Drugs Sales Market Share by Region (2017-2028)
2.4 Dry Eye Drugs Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Dry Eye Drugs Revenue by Region: 2017-2022
2.4.2 Global Dry Eye Drugs Revenue Forecast by Region (2023-2028)
2.4.3 Global Dry Eye Drugs Revenue Market Share by Region (2017-2028)
3 Global Dry Eye Drugs by Manufacturers
3.1 Global Top Dry Eye Drugs Manufacturers by Sales
3.1.1 Global Dry Eye Drugs Sales by Manufacturer (2017-2022)
3.1.2 Global Dry Eye Drugs Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Dry Eye Drugs Manufacturers by Revenue
3.2.1 Global Dry Eye Drugs Revenue by Manufacturer (2017-2022)
3.2.2 Global Dry Eye Drugs Revenue Share by Manufacturer (2017-2022)
3.3 Global Dry Eye Drugs Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Dry Eye Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global Dry Eye Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Dry Eye Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Dry Eye Drugs Manufacturing Base Distribution, Product Type
3.5.1 Dry Eye Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Dry Eye Drugs Product Type
3.5.3 Date of International Manufacturers Enter into Dry Eye Drugs Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Allergan
4.1.1 Allergan Corporation Information
4.1.2 Allergan Description, Business Overview
4.1.3 Allergan Dry Eye Drugs Products Offered
4.1.4 Allergan Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Allergan Dry Eye Drugs Sales by Product in 2021
4.1.6 Allergan Dry Eye Drugs Sales by Application in 2021
4.1.7 Allergan Dry Eye Drugs Sales by Geographic Area in 2021
4.1.8 Allergan Recent Developments
4.2 Novartis AG
4.2.1 Novartis AG Corporation Information
4.2.2 Novartis AG Description, Business Overview
4.2.3 Novartis AG Dry Eye Drugs Products Offered
4.2.4 Novartis AG Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Novartis AG Dry Eye Drugs Sales by Product in 2021
4.2.6 Novartis AG Dry Eye Drugs Sales by Application in 2021
4.2.7 Novartis AG Dry Eye Drugs Sales by Geographic Area in 2021
4.2.8 Novartis AG Recent Developments
4.3 Bausch Health
4.3.1 Bausch Health Corporation Information
4.3.2 Bausch Health Description, Business Overview
4.3.3 Bausch Health Dry Eye Drugs Products Offered
4.3.4 Bausch Health Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Bausch Health Dry Eye Drugs Sales by Product in 2021
4.3.6 Bausch Health Dry Eye Drugs Sales by Application in 2021
4.3.7 Bausch Health Dry Eye Drugs Sales by Geographic Area in 2021
4.3.8 Bausch Health Recent Developments
4.4 Santen Pharma
4.4.1 Santen Pharma Corporation Information
4.4.2 Santen Pharma Description, Business Overview
4.4.3 Santen Pharma Dry Eye Drugs Products Offered
4.4.4 Santen Pharma Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Santen Pharma Dry Eye Drugs Sales by Product in 2021
4.4.6 Santen Pharma Dry Eye Drugs Sales by Application in 2021
4.4.7 Santen Pharma Dry Eye Drugs Sales by Geographic Area in 2021
4.4.8 Santen Pharma Recent Developments
4.5 Takeda
4.5.1 Takeda Corporation Information
4.5.2 Takeda Description, Business Overview
4.5.3 Takeda Dry Eye Drugs Products Offered
4.5.4 Takeda Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Takeda Dry Eye Drugs Sales by Product in 2021
4.5.6 Takeda Dry Eye Drugs Sales by Application in 2021
4.5.7 Takeda Dry Eye Drugs Sales by Geographic Area in 2021
4.5.8 Takeda Recent Developments
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Corporation Information
4.6.2 Johnson & Johnson Description, Business Overview
4.6.3 Johnson & Johnson Dry Eye Drugs Products Offered
4.6.4 Johnson & Johnson Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Johnson & Johnson Dry Eye Drugs Sales by Product in 2021
4.6.6 Johnson & Johnson Dry Eye Drugs Sales by Application in 2021
4.6.7 Johnson & Johnson Dry Eye Drugs Sales by Geographic Area in 2021
4.6.8 Johnson & Johnson Recent Development
4.7 United Laboratories
4.7.1 United Laboratories Corporation Information
4.7.2 United Laboratories Description, Business Overview
4.7.3 United Laboratories Dry Eye Drugs Products Offered
4.7.4 United Laboratories Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.7.5 United Laboratories Dry Eye Drugs Sales by Product in 2021
4.7.6 United Laboratories Dry Eye Drugs Sales by Application in 2021
4.7.7 United Laboratories Dry Eye Drugs Sales by Geographic Area in 2021
4.7.8 United Laboratories Recent Development
4.8 Senju Pharmaceutical
4.8.1 Senju Pharmaceutical Corporation Information
4.8.2 Senju Pharmaceutical Description, Business Overview
4.8.3 Senju Pharmaceutical Dry Eye Drugs Products Offered
4.8.4 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Senju Pharmaceutical Dry Eye Drugs Sales by Product in 2021
4.8.6 Senju Pharmaceutical Dry Eye Drugs Sales by Application in 2021
4.8.7 Senju Pharmaceutical Dry Eye Drugs Sales by Geographic Area in 2021
4.8.8 Senju Pharmaceutical Recent Development
4.9 Jianfeng Group
4.9.1 Jianfeng Group Corporation Information
4.9.2 Jianfeng Group Description, Business Overview
4.9.3 Jianfeng Group Dry Eye Drugs Products Offered
4.9.4 Jianfeng Group Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Jianfeng Group Dry Eye Drugs Sales by Product in 2021
4.9.6 Jianfeng Group Dry Eye Drugs Sales by Application in 2021
4.9.7 Jianfeng Group Dry Eye Drugs Sales by Geographic Area in 2021
4.9.8 Jianfeng Group Recent Development
4.10 Eusan GMBH
4.10.1 Eusan GMBH Corporation Information
4.10.2 Eusan GMBH Description, Business Overview
4.10.3 Eusan GMBH Dry Eye Drugs Products Offered
4.10.4 Eusan GMBH Dry Eye Drugs Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Eusan GMBH Dry Eye Drugs Sales by Product in 2021
4.10.6 Eusan GMBH Dry Eye Drugs Sales by Application in 2021
4.10.7 Eusan GMBH Dry Eye Drugs Sales by Geographic Area in 2021
4.10.8 Eusan GMBH Recent Development
5 Breakdown Data by Type
5.1 Global Dry Eye Drugs Sales by Type (2017-2028)
5.1.1 Global Dry Eye Drugs Sales by Type (2017-2022)
5.1.2 Global Dry Eye Drugs Sales Forecast by Type (2023-2028)
5.1.3 Global Dry Eye Drugs Sales Market Share by Type (2017-2028)
5.2 Global Dry Eye Drugs Revenue Forecast by Type (2017-2028)
5.2.1 Global Dry Eye Drugs Revenue by Type (2017-2022)
5.2.2 Global Dry Eye Drugs Revenue Forecast by Type (2023-2028)
5.2.3 Global Dry Eye Drugs Revenue Market Share by Type (2017-2028)
5.3 Dry Eye Drugs Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Dry Eye Drugs Sales by Application (2017-2028)
6.1.1 Global Dry Eye Drugs Sales by Application (2017-2022)
6.1.2 Global Dry Eye Drugs Sales Forecast by Application (2023-2028)
6.1.3 Global Dry Eye Drugs Sales Market Share by Application (2017-2028)
6.2 Global Dry Eye Drugs Revenue Forecast by Application (2017-2028)
6.2.1 Global Dry Eye Drugs Revenue by Application (2017-2022)
6.2.2 Global Dry Eye Drugs Revenue Forecast by Application (2023-2028)
6.2.3 Global Dry Eye Drugs Revenue Market Share by Application (2017-2028)
6.3 Dry Eye Drugs Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Dry Eye Drugs Market Size YoY Growth 2017-2028
7.2 North America Dry Eye Drugs Market Facts & Figures by Country
7.2.1 North America Dry Eye Drugs Sales by Country (2017-2028)
7.2.2 North America Dry Eye Drugs Revenue by Country (2017-2028)
7.3 North America Dry Eye Drugs Sales by Type
7.4 North America Dry Eye Drugs Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Dry Eye Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Dry Eye Drugs Market Facts & Figures by Region
8.2.1 Asia-Pacific Dry Eye Drugs Sales by Region (2017-2028)
8.2.2 Asia-Pacific Dry Eye Drugs Revenue by Region (2017-2028)
8.3 Asia-Pacific Dry Eye Drugs Sales by Type
8.4 Asia-Pacific Dry Eye Drugs Sales by Application
9 Europe
9.1 Europe Dry Eye Drugs Market Size YoY Growth 2017-2028
9.2 Europe Dry Eye Drugs Market Facts & Figures by Country
9.2.1 Europe Dry Eye Drugs Sales by Country (2017-2028)
9.2.2 Europe Dry Eye Drugs Revenue by Country (2017-2028)
9.3 Europe Dry Eye Drugs Sales by Type
9.4 Europe Dry Eye Drugs Sales by Application
10 Latin America
10.1 Latin America Dry Eye Drugs Market Size YoY Growth 2017-2028
10.2 Latin America Dry Eye Drugs Market Facts & Figures by Country
10.2.1 Latin America Dry Eye Drugs Sales by Country (2017-2028)
10.2.2 Latin America Dry Eye Drugs Revenue by Country (2017-2028)
10.3 Latin America Dry Eye Drugs Sales by Type
10.4 Latin America Dry Eye Drugs Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Dry Eye Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Dry Eye Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Dry Eye Drugs Sales by Country (2017-2028)
11.2.2 Middle East and Africa Dry Eye Drugs Revenue by Country (2017-2028)
11.3 Middle East and Africa Dry Eye Drugs Sales by Type
11.4 Middle East and Africa Dry Eye Drugs Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Dry Eye Drugs Supply Chain Analysis
12.2 Dry Eye Drugs Key Raw Materials and Upstream Suppliers
12.3 Dry Eye Drugs Clients Analysis
12.4 Dry Eye Drugs Sales Channel and Sales Model Analysis
12.4.1 Dry Eye Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Dry Eye Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Dry Eye Drugs Distributors
13 Market Dynamics
13.1 Dry Eye Drugs Industry Trends
13.2 Dry Eye Drugs Market Drivers
13.3 Dry Eye Drugs Market Challenges
13.4 Dry Eye Drugs Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dry Eye Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Artificial Tears
Table 3. Major Manufacturers of Anti-inflammatory Drugs
Table 4. Major Manufacturers of Other
Table 5. Global Dry Eye Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Dry Eye Drugs Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 7. Global Dry Eye Drugs Sales by Region (2017-2022) & (K Units)
Table 8. Global Dry Eye Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 9. Global Dry Eye Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Dry Eye Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Global Dry Eye Drugs Sales by Manufacturer (2017-2022) & (K Units)
Table 12. Global Dry Eye Drugs Sales Share by Manufacturer (2017-2022)
Table 13. Dry Eye Drugs Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 14. Dry Eye Drugs Revenue Share by Manufacturer (2017-2022)
Table 15. Key Manufacturers Dry Eye Drugs Price (2017-2022) & (USD/Unit)
Table 16. Ranking of Global Top Dry Eye Drugs Manufacturers by Revenue (US$ Million) in 2021
Table 17. Global Dry Eye Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 18. Global Dry Eye Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dry Eye Drugs as of 2021)
Table 19. Dry Eye Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Dry Eye Drugs Product Type
Table 21. Date of International Manufacturers Enter into Dry Eye Drugs Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Allergan Corporation Information
Table 24. Allergan Description and Business Overview
Table 25. Allergan Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 26. Allergan Dry Eye Drugs Product
Table 27. Allergan Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 28. Allergan Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 29. Allergan Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 30. Allergan Recent Development
Table 31. Novartis AG Corporation Information
Table 32. Novartis AG Description and Business Overview
Table 33. Novartis AG Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 34. Novartis AG Dry Eye Drugs Product
Table 35. Novartis AG Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 36. Novartis AG Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 37. Novartis AG Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 38. Novartis AG Recent Development
Table 39. Bausch Health Corporation Information
Table 40. Bausch Health Description and Business Overview
Table 41. Bausch Health Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 42. Bausch Health Dry Eye Drugs Product
Table 43. Bausch Health Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 44. Bausch Health Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 45. Bausch Health Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 46. Bausch Health Recent Development
Table 47. Santen Pharma Corporation Information
Table 48. Santen Pharma Description and Business Overview
Table 49. Santen Pharma Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Santen Pharma Dry Eye Drugs Product
Table 51. Santen Pharma Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 52. Santen Pharma Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 53. Santen Pharma Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 54. Santen Pharma Recent Development
Table 55. Takeda Corporation Information
Table 56. Takeda Description and Business Overview
Table 57. Takeda Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 58. Takeda Dry Eye Drugs Product
Table 59. Takeda Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 60. Takeda Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 61. Takeda Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 62. Takeda Recent Development
Table 63. Johnson & Johnson Corporation Information
Table 64. Johnson & Johnson Description and Business Overview
Table 65. Johnson & Johnson Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 66. Johnson & Johnson Dry Eye Drugs Product
Table 67. Johnson & Johnson Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 68. Johnson & Johnson Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 69. Johnson & Johnson Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 70. United Laboratories Corporation Information
Table 71. United Laboratories Description and Business Overview
Table 72. United Laboratories Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 73. United Laboratories Dry Eye Drugs Product
Table 74. United Laboratories Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 75. United Laboratories Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 76. United Laboratories Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 77. Senju Pharmaceutical Corporation Information
Table 78. Senju Pharmaceutical Description and Business Overview
Table 79. Senju Pharmaceutical Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Senju Pharmaceutical Dry Eye Drugs Product
Table 81. Senju Pharmaceutical Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 82. Senju Pharmaceutical Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 83. Senju Pharmaceutical Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 84. Jianfeng Group Corporation Information
Table 85. Jianfeng Group Description and Business Overview
Table 86. Jianfeng Group Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Jianfeng Group Dry Eye Drugs Product
Table 88. Jianfeng Group Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 89. Jianfeng Group Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 90. Jianfeng Group Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 91. Eusan GMBH Corporation Information
Table 92. Eusan GMBH Description and Business Overview
Table 93. Eusan GMBH Dry Eye Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 94. Eusan GMBH Dry Eye Drugs Product
Table 95. Eusan GMBH Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Product in 2021
Table 96. Eusan GMBH Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Application in 2021
Table 97. Eusan GMBH Dry Eye Drugs Sales Proportion of Dry Eye Drugs by Geographic Area in 2021
Table 98. Global Dry Eye Drugs Sales by Type (2017-2022) & (K Units)
Table 99. Global Dry Eye Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 100. Global Dry Eye Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 101. Global Dry Eye Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 102. Global Dry Eye Drugs Sales by Application (2017-2022) & (K Units)
Table 103. Global Dry Eye Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 104. Global Dry Eye Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 105. Global Dry Eye Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 106. North America Dry Eye Drugs Sales by Country (2017-2022) & (K Units)
Table 107. North America Dry Eye Drugs Sales by Country (2023-2028) & (K Units)
Table 108. North America Dry Eye Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 109. North America Dry Eye Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 110. North America Dry Eye Drugs Sales by Type (2017-2022) & (K Units)
Table 111. North America Dry Eye Drugs Sales by Application (2017-2022) & (K Units)
Table 112. Asia-Pacific Dry Eye Drugs Sales by Region (2017-2022) & (K Units)
Table 113. Asia-Pacific Dry Eye Drugs Sales by Region (2023-2028) & (K Units)
Table 114. Asia-Pacific Dry Eye Drugs Revenue by Region (2017-2028) & (US$ Million)
Table 115. Asia-Pacific Dry Eye Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 116. Asia-Pacific Dry Eye Drugs Sales by Type (2017-2022) & (K Units)
Table 117. Asia-Pacific Dry Eye Drugs Sales by Application (2017-2022) & (K Units)
Table 118. Europe Dry Eye Drugs Sales by Country (2017-2022) & (K Units)
Table 119. Europe Dry Eye Drugs Sales by Country (2023-2028) & (K Units)
Table 120. Europe Dry Eye Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 121. Europe Dry Eye Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 122. Europe Dry Eye Drugs Sales by Type (2017-2022) & (K Units)
Table 123. Europe Dry Eye Drugs Sales by Application (2017-2022) & (K Units)
Table 124. Latin America Dry Eye Drugs Sales by Country (2017-2022) & (K Units)
Table 125. Latin America Dry Eye Drugs Sales by Country (2023-2028) & (K Units)
Table 126. Latin America Dry Eye Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 127. Latin America Dry Eye Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 128. Latin America Dry Eye Drugs Sales by Type (2017-2022) & (K Units)
Table 129. Latin America Dry Eye Drugs Sales by Application (2017-2022) & (K Units)
Table 130. Middle East and Africa Dry Eye Drugs Sales by Country (2017-2022) & (K Units)
Table 131. Middle East and Africa Dry Eye Drugs Sales by Country (2023-2028) & (K Units)
Table 132. Middle East and Africa Dry Eye Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 133. Middle East and Africa Dry Eye Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 134. Middle East and Africa Dry Eye Drugs Sales by Type (2017-2022) & (K Units)
Table 135. Middle East and Africa Dry Eye Drugs Sales by Application (2017-2022) & (K Units)
Table 136. Dry Eye Drugs Key Raw Materials, Industry Status and Trend
Table 137. Dry Eye Drugs Key Raw Materials and Upstream Suppliers
Table 138. Dry Eye Drugs Clients Status and Trend
Table 139. Dry Eye Drugs Typical Clients
Table 140. Dry Eye Drugs Distributors
Table 141. Dry Eye Drugs Market Trends
Table 142. Dry Eye Drugs Market Drivers
Table 143. Dry Eye Drugs Market Challenges
Table 144. Dry Eye Drugs Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Dry Eye Drugs Product Picture
Figure 2. Global Dry Eye Drugs Sales Market Share by Type in 2021 & 2028
Figure 3. Artificial Tears Product Picture
Figure 4. Anti-inflammatory Drugs Product Picture
Figure 5. Other Product Picture
Figure 6. Global Dry Eye Drugs Sales Market Share by Application in 2021 & 2028
Figure 7. Hospital Examples
Figure 8. Drug Stores Examples
Figure 9. Online Pharmacies Examples
Figure 10. Dry Eye Drugs Report Years Considered
Figure 11. Global Dry Eye Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Dry Eye Drugs Market Size 2017-2028 (US$ Million)
Figure 13. Global Dry Eye Drugs Sales 2017-2028 (K Units)
Figure 14. Global Dry Eye Drugs Market Size Market Share by Region: 2022 Versus 2028
Figure 15. Global Dry Eye Drugs Sales Market Share Forecast by Region (2017-2028)
Figure 16. Global Dry Eye Drugs Revenue Market Share by Region (2017-2028)
Figure 17. Global Dry Eye Drugs Sales Share by Manufacturer in 2021
Figure 18. Dry Eye Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 19. Global Dry Eye Drugs Sales Market Share Forecast by Type (2017-2028)
Figure 20. Global Dry Eye Drugs Revenue Market Share Forecast by Type (2017-2028)
Figure 21. Dry Eye Drugs Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
Figure 22. Global Dry Eye Drugs Sales Market Share Forecast by Application (2017-2028)
Figure 23. Global Dry Eye Drugs Revenue Market Share Forecast by Application (2017-2028)
Figure 24. Dry Eye Drugs Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
Figure 25. North America Dry Eye Drugs Revenue 2017-2028 (US$ Million)
Figure 26. North America Dry Eye Drugs Sales Market Share by Type (2017-2022)
Figure 27. North America Dry Eye Drugs Sales Market Share by Application (2017-2022)
Figure 28. Asia-Pacific Dry Eye Drugs Revenue 2017-2028 (US$ Million)
Figure 29. Asia-Pacific Dry Eye Drugs Sales Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Dry Eye Drugs Revenue Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Dry Eye Drugs Sales Market Share by Type (2017-2022)
Figure 32. Asia-Pacific Dry Eye Drugs Sales Market Share by Application (2017-2022)
Figure 33. Europe Dry Eye Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 34. Europe Dry Eye Drugs Sales Market Share by Country (2017-2028)
Figure 35. Europe Dry Eye Drugs Revenue Market Share by Country (2017-2028)
Figure 36. Europe Dry Eye Drugs Sales Market Share by Type (2017-2022)
Figure 37. Europe Dry Eye Drugs Sales Market Share by Application (2017-2022)
Figure 38. Latin America Dry Eye Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 39. Latin America Dry Eye Drugs Sales Market Share by Country (2017-2028)
Figure 40. Latin America Dry Eye Drugs Revenue Market Share by Country (2017-2022)
Figure 41. Latin America Dry Eye Drugs Sales Market Share by Type (2017-2022)
Figure 42. Latin America Dry Eye Drugs Sales Market Share by Application (2017-2022)
Figure 43. Middle East and Africa Dry Eye Drugs Revenue Growth Rate 2017-2028 (US$ Million)
Figure 44. Middle East and Africa Dry Eye Drugs Sales Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Dry Eye Drugs Revenue Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Dry Eye Drugs Sales Market Share by Type (2017-2022)
Figure 47. Middle East and Africa Dry Eye Drugs Sales Market Share by Application (2017-2022)
Figure 48. Dry Eye Drugs Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Dry Eye Drugs Raw Materials by Region in 2021
Figure 50. Dry Eye Drugs Distribution Channels
Figure 51. Global Dry Eye Drugs Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 52. Global Dry Eye Drugs Percentage 2017-2028: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs